Johnson & Johnson guides to 8.2% adjusted EPS growth at its 2026 midpoint, compared with approximately 7% implied by 2026 ...

The Company remains on track to complete 12-month visits by early Q2 2027. Envoy Medical has submitted two of the four ...

Abbott Laboratories (NYSE:ABT) is one of the top 10 picks in President Trump’s latest stock portfolio. Trump bought $1 ...

Medical researchers reported remarkable progress in 2026, introducing new treatments and technologies that could transform ...

Soon if you visit a medical specialist, you may notice a fact sheet plastered on the wall. It will encourage you to ask questions, and outline five simple things to consider when speaking to your ...

A second victim of the September 11 attacks has been identified with breakthrough genetic genealogy, which combines DNA ...

Washington State University researchers have engineered a targeted nanotherapy that could yield a medical breakthrough to ...

Companies are required to warn that experimental peptides, which haven’t been approved by the FDA, are for research use only.

Remaining milestones: The company expects to submit two additional modules, including the final module containing clinical trial data, towards the end of the second quarter in 2027.

OH, occurs naturally in trace amounts in kratom leaves, but products containing concentrated 7-OH — sometimes called “gas station heroin” — are now sold as tablets, gummies and liquid shots at gas ...

Doctors are more likely to dismiss women’s symptoms as being “all in their head” than those of male patients, research ...

Second of Four Planned Modules Moves Rolling FDA Review Forward Advances Toward Targeted Completion of the Final Clinical ...